Drugs / dGH
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02410356 Comparator | Apr 2015 → Feb 2016 | pituitary deficiency | Teva Branded Pharmaceutical Products R&D, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dGH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02410356 ↗ |
| Route | Other | “dGH to be given as daily injections.” NCT02410356 ↗ |